When to Start Levodopa Therapy for Parkinson's Disease

被引：18

作者：

Bressman, Susan ^{[1
]}

Saunders-Pullman, Rachel ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2019年 / 380卷 / 04期

关键词：

INITIAL TREATMENT;

D O I：

10.1056/NEJMe1814611

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：389 / 390

页数：2

共 11 条

[1]

Fahn S, 2004, NEW ENGL J MED, V351, P2498

[2] Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised [J].

Gray, Richard ;

Ives, Natalie ;

Rick, Caroline ;

Patel, Smitaa ;

Gray, Alastair ;

Jenkinson, Crispin ;

McIntosh, Emma ;

Wheatley, Keith ;

Williams, Adrian ;

Clarke, Carl E. ;

Sandercock, P. ;

Baigent, C. ;

Crome, P. ;

Williams, A. ;

Abbott, R. ;

Baker, M. ;

Castleton, B. ;

Clarke, C. E. ;

Counsell, C. ;

Deb, A. K. ;

Fairweather, S. ;

Fitzpatrick, R. ;

Gray, A. ;

Ives, N. ;

Jenkinson, C. ;

MacPhee, G. ;

Malone, T. ;

Mant, D. ;

McIntosh, E. ;

Ming, A. ;

Morrish, P. ;

Ohri, P. ;

Pearce, V. ;

Wood, B. ;

Worth, P. ;

Au, P. ;

Boodell, T. ;

Cheed, V. ;

Clarke, C. E. ;

Daniels, J. ;

Dowling, F. ;

Edmondson, A. ;

Gray, R. ;

Hawker, R. ;

Herd, C. ;

Hilken, N. ;

Ives, N. ;

Kaur, S. ;

Ottridge, R. ;

Patel, S. .

LANCET, 2014, 384 (9949) :1196-1205

[3]

Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044

[4] Levodopa in Parkinson's disease - Neurotoxicity issue laid to rest? [J].

Murer, MG ;

Raisman-Vozari, R ;

Gershanik, O .

DRUG SAFETY, 1999, 21 (05) :339-352

[5] Clinical approaches to the development of a neuroprotective therapy for PD [J].

Olanow, C. W. ;

Kieburtz, K. ;

Katz, R. .

EXPERIMENTAL NEUROLOGY, 2017, 298 :246-251

[6] Levodopa: A New Look at An Old Friend [J].

Olanow, C. Warren ;

Stocchi, Fabrizio .

MOVEMENT DISORDERS, 2018, 33 (06) :859-866

[7] Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease [J].

Olanow, C. Warren ;

Kieburtz, Karl ;

Rascol, Olivier ;

Poewe, Werner ;

Schapira, Anthony H. ;

Emre, Murat ;

Nissinen, Helena ;

Leinonen, Mika ;

Stocchi, Fabrizio .

MOVEMENT DISORDERS, 2013, 28 (08) :1064-1071

[8]

Parkinson Study Group, 2000, JAMA, V284, P1931

[9] Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic [J].

Sardi, S. Pablo ;

Cedarbaum, Jesse M. ;

Brundin, Patrik .

MOVEMENT DISORDERS, 2018, 33 (05) :684-696

[10] Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease The STRIDE-PD Study [J].

Stocchi, Fabrizio ;

Rascol, Olivier ;

Kieburtz, Karl ;

Poewe, Werner ;

Jankovic, Joseph ;

Tolosa, Eduardo ;

Barone, Paulo ;

Lang, Anthony E. ;

Olanow, C. Warren .

ANNALS OF NEUROLOGY, 2010, 68 (01) :18-27

← 1 2 →